Sector

Information Technology

122 companies under coverage across 12 industries.

Industries

Browse by industry

Application Software 25 Communications Equipment 8 Electronic Components 4 Electronic Equipment & Instruments 8 Electronic Manufacturing Services 7 Internet Services & Infrastructure 4 IT Consulting & Other Services 5 Semiconductor Materials & Equipment 9 Semiconductors 27 Systems Software 12 Technology Distributors 4 Technology Hardware, Storage & Peripherals 9

Coverage

Information Technology companies

Equity Research

Cirrus Logic Inc (CRUS)

BUY. 12-month probability-weighted target $133 (+24% vs spot). P/E Multiple explains 69% of Monte Carlo outcome variance.

CRUSEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +32.0%

Equity Research

Cerebras Systems Inc. Class A Common Stock (CBRS)

BUY. 12-month probability-weighted target $206 (+25% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

CBRSEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +21.3%

Equity Research

First Solar Inc. (FSLR)

BUY. 12-month probability-weighted target $230 (+29% vs spot). P/E Multiple explains 71% of Monte Carlo outcome variance.

FSLREquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +18.0%

Equity Research

IPG Photonics Corporation (IPGP)

BUY. 12-month probability-weighted target $96 (+22% vs spot). P/E Multiple explains 72% of Monte Carlo outcome variance.

IPGPEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +17.4%

Equity Research

Vontier Corp (VNT)

BUY. 12-month probability-weighted target $41 (+28% vs spot). P/E Multiple explains 60% of Monte Carlo outcome variance.

VNTEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +14.7%

Equity Research

Amkor Technology Inc (AMKR)

BUY. 12-month probability-weighted target $61 (+24% vs spot). Gross Margin explains 57% of Monte Carlo outcome variance.

AMKREquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +14.0%

Equity Research

NXP Semiconductors NV (NXPI)

HOLD. 12-month probability-weighted target $263 (+15% vs spot). P/E Multiple explains 76% of Monte Carlo outcome variance.

NXPIEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +12.7%

Equity Research

Bill Com Holdings Inc (BILL)

HOLD. 12-month probability-weighted target $43 (-5% vs spot). P/E Multiple explains 77% of Monte Carlo outcome variance.

BILLEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +8.1%

Equity Research

KLA Corporation (KLAC)

BUY. 12-month probability-weighted target $245 (+25% vs spot). P/E Multiple explains 82% of Monte Carlo outcome variance.

KLACEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +7.2%

Equity Research

Qnity Electronics, Inc (Q)

BUY. 12-month probability-weighted target $151 (+19% vs spot). P/E Multiple explains 65% of Monte Carlo outcome variance.

QEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +6.3%

Equity Research

Allegro Microsystems Inc (ALGM)

BUY. 12-month probability-weighted target $46 (+29% vs spot). P/E Multiple explains 68% of Monte Carlo outcome variance.

ALGMEquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +6.3%

Equity Research

ON Semiconductor Corporation (ON)

HOLD. 12-month probability-weighted target $87 (+12% vs spot). P/E Multiple explains 73% of Monte Carlo outcome variance.

ONEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +6.1%

Equity Research

Qualcomm Incorporated (QCOM)

HOLD. 12-month probability-weighted target $174 (-1% vs spot). P/E Multiple explains 73% of Monte Carlo outcome variance.

QCOMEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +5.7%

Equity Research

Universal Display (OLED)

HOLD. 12-month probability-weighted target $79 (+5% vs spot). P/E Multiple explains 77% of Monte Carlo outcome variance.

OLEDEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +5.7%

Equity Research

Microchip Technology Inc (MCHP)

HOLD. 12-month probability-weighted target $83 (+9% vs spot). P/E Multiple explains 79% of Monte Carlo outcome variance.

MCHPEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +4.7%

Equity Research

Coherent Inc (COHR)

BUY. 12-month probability-weighted target $371 (+19% vs spot). P/E Multiple explains 78% of Monte Carlo outcome variance.

COHREquity ResearchMonte Carlo

10 October 2026Rating: BUY · Fair value vs price +3.2%

Equity Research

Western Digital Corporation (WDC)

HOLD. 12-month probability-weighted target $435 (+10% vs spot). P/E Multiple explains 83% of Monte Carlo outcome variance.

WDCEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price +1.9%

Equity Research

Uipath Inc (PATH)

SELL. 12-month probability-weighted target $11 (-16% vs spot). P/E Multiple explains 79% of Monte Carlo outcome variance.

PATHEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -1.0%

Equity Research

Applied Materials Inc (AMAT)

HOLD. 12-month probability-weighted target $621 (+23% vs spot). P/E Multiple explains 79% of Monte Carlo outcome variance.

AMATEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -1.2%

Equity Research

Dolby Laboratories (DLB)

SELL. 12-month probability-weighted target $49 (-16% vs spot). P/E Multiple explains 86% of Monte Carlo outcome variance.

DLBEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -1.8%

Equity Research

Pegasystems Inc (PEGA)

SELL. 12-month probability-weighted target $31 (-13% vs spot). P/E Multiple explains 77% of Monte Carlo outcome variance.

PEGAEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -2.3%

Equity Research

Flex Ltd (FLEX)

HOLD. 12-month probability-weighted target $143 (+19% vs spot). Gross Margin explains 59% of Monte Carlo outcome variance.

FLEXEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -2.4%

Equity Research

Jabil Circuit Inc (JBL)

HOLD. 12-month probability-weighted target $339 (+11% vs spot). Gross Margin explains 59% of Monte Carlo outcome variance.

JBLEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -3.8%

Equity Research

Oracle Corporation (ORCL)

HOLD. 12-month probability-weighted target $145 (+2% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

ORCLEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -4.5%

Equity Research

Adobe Systems Incorporated (ADBE)

SELL. 12-month probability-weighted target $198 (-18% vs spot). P/E Multiple explains 89% of Monte Carlo outcome variance.

ADBEEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -4.8%

Equity Research

MKS Instruments Inc (MKSI)

HOLD. 12-month probability-weighted target $285 (+8% vs spot). P/E Multiple explains 68% of Monte Carlo outcome variance.

MKSIEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -5.0%

Equity Research

International Business Machines (IBM)

HOLD. 12-month probability-weighted target $257 (+13% vs spot). P/E Multiple explains 58% of Monte Carlo outcome variance.

IBMEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -5.4%

Equity Research

Gen Digital Inc. (GEN)

HOLD. 12-month probability-weighted target $23 (+0% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

GENEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -6.2%

Equity Research

Intuit Inc (INTU)

SELL. 12-month probability-weighted target $245 (-19% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

INTUEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -6.4%

Equity Research

Advanced Energy Industries Inc (AEIS)

HOLD. 12-month probability-weighted target $277 (-4% vs spot). P/E Multiple explains 71% of Monte Carlo outcome variance.

AEISEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -6.8%

Equity Research

Skyworks Solutions Inc (SWKS)

SELL. 12-month probability-weighted target $66 (-13% vs spot). P/E Multiple explains 65% of Monte Carlo outcome variance.

SWKSEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -6.9%

Equity Research

NVIDIA Corporation (NVDA)

SELL. 12-month probability-weighted target $199 (-13% vs spot). Revenue Growth explains 59% of Monte Carlo outcome variance.

NVDAEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -7.5%

Equity Research

Sanmina Corporation (SANM)

HOLD. 12-month probability-weighted target $206 (-5% vs spot). Gross Margin explains 59% of Monte Carlo outcome variance.

SANMEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -7.6%

Equity Research

Cisco Systems Inc (CSCO)

HOLD. 12-month probability-weighted target $111 (-6% vs spot). P/E Multiple explains 83% of Monte Carlo outcome variance.

CSCOEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -7.9%

Equity Research

Texas Instruments Incorporated (TXN)

HOLD. 12-month probability-weighted target $276 (-3% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

TXNEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -8.3%

Equity Research

Rambus Inc (RMBS)

SELL. 12-month probability-weighted target $98 (-9% vs spot). P/E Multiple explains 82% of Monte Carlo outcome variance.

RMBSEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -8.6%

Equity Research

Bentley Systems Inc (BSY)

HOLD. 12-month probability-weighted target $32 (-10% vs spot). P/E Multiple explains 78% of Monte Carlo outcome variance.

BSYEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -9.1%

Equity Research

Akamai Technologies Inc (AKAM)

HOLD. 12-month probability-weighted target $111 (+4% vs spot). P/E Multiple explains 73% of Monte Carlo outcome variance.

AKAMEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -9.3%

Equity Research

Littelfuse Inc (LFUS)

HOLD. 12-month probability-weighted target $402 (-6% vs spot). P/E Multiple explains 63% of Monte Carlo outcome variance.

LFUSEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -9.7%

Equity Research

CommVault Systems Inc (CVLT)

HOLD. 12-month probability-weighted target $144 (-9% vs spot). P/E Multiple explains 70% of Monte Carlo outcome variance.

CVLTEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -9.9%

Equity Research

Tyler Technologies Inc (TYL)

SELL. 12-month probability-weighted target $273 (-17% vs spot). P/E Multiple explains 73% of Monte Carlo outcome variance.

TYLEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -10.0%

Equity Research

Corning Incorporated (GLW)

HOLD. 12-month probability-weighted target $178 (+13% vs spot). P/E Multiple explains 64% of Monte Carlo outcome variance.

GLWEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -10.1%

Equity Research

Cadence Design Systems Inc (CDNS)

HOLD. 12-month probability-weighted target $372 (+5% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

CDNSEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -10.1%

Equity Research

Autodesk Inc (ADSK)

SELL. 12-month probability-weighted target $190 (-19% vs spot). P/E Multiple explains 91% of Monte Carlo outcome variance.

ADSKEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -10.1%

Equity Research

Cognex Corporation (CGNX)

HOLD. 12-month probability-weighted target $62 (-2% vs spot). P/E Multiple explains 77% of Monte Carlo outcome variance.

CGNXEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -10.3%

Equity Research

Lam Research Corp (LRCX)

HOLD. 12-month probability-weighted target $309 (-3% vs spot). P/E Multiple explains 72% of Monte Carlo outcome variance.

LRCXEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -10.4%

Equity Research

Arrow Electronics Inc (ARW)

HOLD. 12-month probability-weighted target $213 (-6% vs spot). Gross Margin explains 66% of Monte Carlo outcome variance.

ARWEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -11.1%

Equity Research

Analog Devices Inc (ADI)

HOLD. 12-month probability-weighted target $375 (-8% vs spot). P/E Multiple explains 82% of Monte Carlo outcome variance.

ADIEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -11.5%

Equity Research

Onto Innovation Inc (ONTO)

HOLD. 12-month probability-weighted target $272 (-8% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

ONTOEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -12.2%

Equity Research

Teledyne Technologies Incorporated (TDY)

HOLD. 12-month probability-weighted target $603 (-2% vs spot). P/E Multiple explains 64% of Monte Carlo outcome variance.

TDYEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -13.8%

Equity Research

Kyndryl Holdings Inc (KD)

HOLD. 12-month probability-weighted target $13 (+8% vs spot). Gross Margin explains 64% of Monte Carlo outcome variance.

KDEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -13.8%

Equity Research

Trimble Inc (TRMB)

SELL. 12-month probability-weighted target $48 (-20% vs spot). P/E Multiple explains 74% of Monte Carlo outcome variance.

TRMBEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -14.2%

Equity Research

Synaptics Incorporated (SYNA)

HOLD. 12-month probability-weighted target $109 (-9% vs spot). P/E Multiple explains 61% of Monte Carlo outcome variance.

SYNAEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -15.1%

Equity Research

Motorola Solutions Inc (MSI)

SELL. 12-month probability-weighted target $396 (-11% vs spot). P/E Multiple explains 75% of Monte Carlo outcome variance.

MSIEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -15.5%

Equity Research

TE Connectivity Ltd (TEL)

SELL. 12-month probability-weighted target $185 (-15% vs spot). P/E Multiple explains 69% of Monte Carlo outcome variance.

TELEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -15.7%

Equity Research

Belden Inc (BDC)

HOLD. 12-month probability-weighted target $102 (-6% vs spot). P/E Multiple explains 48% of Monte Carlo outcome variance.

BDCEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -15.9%

Equity Research

Crane NXT Co (CXT)

HOLD. 12-month probability-weighted target $51 (+1% vs spot). P/E Multiple explains 55% of Monte Carlo outcome variance.

CXTEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -16.6%

Equity Research

Ciena Corp (CIEN)

HOLD. 12-month probability-weighted target $473 (+5% vs spot). P/E Multiple explains 67% of Monte Carlo outcome variance.

CIENEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -17.1%

Equity Research

Qualys Inc (QLYS)

SELL. 12-month probability-weighted target $152 (-25% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

QLYSEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -17.6%

Equity Research

Guidewire Software Inc (GWRE)

SELL. 12-month probability-weighted target $147 (-12% vs spot). P/E Multiple explains 77% of Monte Carlo outcome variance.

GWREEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -17.7%

Equity Research

F5 Networks Inc (FFIV)

SELL. 12-month probability-weighted target $361 (-25% vs spot). P/E Multiple explains 82% of Monte Carlo outcome variance.

FFIVEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -18.0%

Equity Research

Dropbox Inc (DBX)

SELL. 12-month probability-weighted target $30 (-14% vs spot). P/E Multiple explains 78% of Monte Carlo outcome variance.

DBXEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -18.0%

Equity Research

VeriSign Inc (VRSN)

SELL. 12-month probability-weighted target $252 (-17% vs spot). P/E Multiple explains 89% of Monte Carlo outcome variance.

VRSNEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -18.3%

Equity Research

Microsoft Corporation (MSFT)

SELL. 12-month probability-weighted target $416 (-22% vs spot). P/E Multiple explains 87% of Monte Carlo outcome variance.

MSFTEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -18.5%

Equity Research

Viavi Solutions Inc (VIAV)

SELL. 12-month probability-weighted target $39 (-15% vs spot). P/E Multiple explains 79% of Monte Carlo outcome variance.

VIAVEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -18.9%

Equity Research

Avnet Inc (AVT)

SELL. 12-month probability-weighted target $83 (-16% vs spot). Gross Margin explains 66% of Monte Carlo outcome variance.

AVTEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -19.6%

Equity Research

Synopsys Inc (SNPS)

SELL. 12-month probability-weighted target $440 (-14% vs spot). P/E Multiple explains 82% of Monte Carlo outcome variance.

SNPSEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -20.4%

Equity Research

DocuSign Inc (DOCU)

SELL. 12-month probability-weighted target $48 (-32% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

DOCUEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -20.6%

Equity Research

Manhattan Associates Inc (MANH)

SELL. 12-month probability-weighted target $161 (-21% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

MANHEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -20.7%

Equity Research

Roper Technologies Inc (ROP)

HOLD. 12-month probability-weighted target $324 (-11% vs spot). P/E Multiple explains 75% of Monte Carlo outcome variance.

ROPEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -21.2%

Equity Research

MACOM Technology Solutions Holdings Inc (MTSI)

SELL. 12-month probability-weighted target $266 (-19% vs spot). P/E Multiple explains 83% of Monte Carlo outcome variance.

MTSIEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -21.6%

Equity Research

Keysight Technologies Inc (KEYS)

SELL. 12-month probability-weighted target $334 (-13% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

KEYSEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -22.1%

Equity Research

InterDigital Inc (IDCC)

SELL. 12-month probability-weighted target $249 (-25% vs spot). P/E Multiple explains 86% of Monte Carlo outcome variance.

IDCCEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -22.4%

Equity Research

Cognizant Technology Solutions Corp Class A (CTSH)

SELL. 12-month probability-weighted target $38 (-36% vs spot). Gross Margin explains 50% of Monte Carlo outcome variance.

CTSHEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -22.6%

Equity Research

Godaddy Inc (GDDY)

SELL. 12-month probability-weighted target $83 (-21% vs spot). P/E Multiple explains 68% of Monte Carlo outcome variance.

GDDYEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -23.0%

Equity Research

Dynatrace Holdings LLC (DT)

SELL. 12-month probability-weighted target $44 (-30% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

DTEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -23.9%

Equity Research

CDW Corp (CDW)

HOLD. 12-month probability-weighted target $129 (-9% vs spot). Gross Margin explains 66% of Monte Carlo outcome variance.

CDWEquity ResearchMonte Carlo

10 October 2026Rating: HOLD · Fair value vs price -25.4%

Equity Research

Super Micro Computer Inc (SMCI)

SELL. 12-month probability-weighted target $30 (-29% vs spot). Gross Margin explains 54% of Monte Carlo outcome variance.

SMCIEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -25.5%

Equity Research

Nutanix Inc (NTNX)

SELL. 12-month probability-weighted target $54 (-27% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

NTNXEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -25.8%

Equity Research

Synnex Corporation (SNX)

SELL. 12-month probability-weighted target $230 (-16% vs spot). Gross Margin explains 66% of Monte Carlo outcome variance.

SNXEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -25.9%

Equity Research

Monolithic Power Systems Inc (MPWR)

SELL. 12-month probability-weighted target $1179 (-15% vs spot). P/E Multiple explains 83% of Monte Carlo outcome variance.

MPWREquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -26.5%

Equity Research

ServiceNow Inc. (NOW)

SELL. 12-month probability-weighted target $99 (-30% vs spot). P/E Multiple explains 94% of Monte Carlo outcome variance.

NOWEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -27.2%

Equity Research

HP Inc (HPQ)

SELL. 12-month probability-weighted target $23 (-23% vs spot). Gross Margin explains 53% of Monte Carlo outcome variance.

HPQEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -27.5%

Equity Research

Lattice Semiconductor Corporation (LSCC)

SELL. 12-month probability-weighted target $113 (-10% vs spot). P/E Multiple explains 83% of Monte Carlo outcome variance.

LSCCEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -29.2%

Equity Research

Workday Inc (WDAY)

SELL. 12-month probability-weighted target $115 (-39% vs spot). P/E Multiple explains 78% of Monte Carlo outcome variance.

WDAYEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -29.3%

Equity Research

Teradyne Inc (TER)

SELL. 12-month probability-weighted target $353 (-12% vs spot). P/E Multiple explains 75% of Monte Carlo outcome variance.

TEREquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -29.9%

Equity Research

Salesforce.com Inc (CRM)

SELL. 12-month probability-weighted target $154 (-33% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

CRMEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -30.1%

Equity Research

Entegris Inc (ENTG)

SELL. 12-month probability-weighted target $131 (-21% vs spot). P/E Multiple explains 62% of Monte Carlo outcome variance.

ENTGEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -31.9%

Equity Research

Twilio Inc (TWLO)

SELL. 12-month probability-weighted target $202 (-30% vs spot). P/E Multiple explains 65% of Monte Carlo outcome variance.

TWLOEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -32.8%

Equity Research

Gartner Inc (IT)

SELL. 12-month probability-weighted target $127 (-33% vs spot). P/E Multiple explains 52% of Monte Carlo outcome variance.

ITEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -32.9%

Equity Research

Apple Inc. (AAPL)

SELL. 12-month probability-weighted target $269 (-20% vs spot). P/E Multiple explains 84% of Monte Carlo outcome variance.

AAPLEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -33.1%

Equity Research

Accenture plc (ACN)

SELL. 12-month probability-weighted target $116 (-44% vs spot). Gross Margin explains 51% of Monte Carlo outcome variance.

ACNEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -33.4%

Equity Research

Lumentum Holdings Inc (LITE)

SELL. 12-month probability-weighted target $829 (-25% vs spot). P/E Multiple explains 80% of Monte Carlo outcome variance.

LITEEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -34.2%

Equity Research

Fortinet Inc (FTNT)

SELL. 12-month probability-weighted target $145 (-26% vs spot). P/E Multiple explains 84% of Monte Carlo outcome variance.

FTNTEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -34.3%

Equity Research

Arista Networks (ANET)

SELL. 12-month probability-weighted target $155 (-28% vs spot). P/E Multiple explains 89% of Monte Carlo outcome variance.

ANETEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -35.9%

Equity Research

Marvell Technology Group Ltd (MRVL)

SELL. 12-month probability-weighted target $227 (-17% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

MRVLEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -36.5%

Equity Research

Datadog Inc (DDOG)

SELL. 12-month probability-weighted target $232 (-21% vs spot). P/E Multiple explains 79% of Monte Carlo outcome variance.

DDOGEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -37.0%

Equity Research

Zscaler Inc. (ZS)

SELL. 12-month probability-weighted target $153 (-34% vs spot). P/E Multiple explains 94% of Monte Carlo outcome variance.

ZSEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -37.1%

Equity Research

PTC Inc (PTC)

SELL. 12-month probability-weighted target $114 (-41% vs spot). P/E Multiple explains 84% of Monte Carlo outcome variance.

PTCEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -37.9%

Equity Research

Semtech Corporation (SMTC)

SELL. 12-month probability-weighted target $123 (-34% vs spot). P/E Multiple explains 75% of Monte Carlo outcome variance.

SMTCEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -39.0%

Equity Research

NetApp Inc (NTAP)

SELL. 12-month probability-weighted target $146 (-39% vs spot). P/E Multiple explains 77% of Monte Carlo outcome variance.

NTAPEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -39.3%

Equity Research

Dell Technologies Inc (DELL)

SELL. 12-month probability-weighted target $383 (-35% vs spot). P/E Multiple explains 55% of Monte Carlo outcome variance.

DELLEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -39.4%

Equity Research

Palantir Technologies (PLTR)

SELL. 12-month probability-weighted target $140 (-33% vs spot). P/E Multiple explains 91% of Monte Carlo outcome variance.

PLTREquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -39.9%

Equity Research

Intel Corporation (INTC)

SELL. 12-month probability-weighted target $82 (-21% vs spot). P/E Multiple explains 55% of Monte Carlo outcome variance.

INTCEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -40.0%

Equity Research

Zebra Technologies Corporation (ZBRA)

SELL. 12-month probability-weighted target $248 (-36% vs spot). P/E Multiple explains 63% of Monte Carlo outcome variance.

ZBRAEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -40.6%

Equity Research

Okta Inc (OKTA)

SELL. 12-month probability-weighted target $144 (-38% vs spot). P/E Multiple explains 76% of Monte Carlo outcome variance.

OKTAEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -41.1%

Equity Research

Advanced Micro Devices Inc (AMD)

SELL. 12-month probability-weighted target $411 (-32% vs spot). P/E Multiple explains 78% of Monte Carlo outcome variance.

AMDEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -48.0%

Equity Research

Crowdstrike Holdings Inc (CRWD)

SELL. 12-month probability-weighted target $142 (-48% vs spot). P/E Multiple explains 81% of Monte Carlo outcome variance.

CRWDEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -50.1%

Equity Research

Palo Alto Networks (PANW)

SELL. 12-month probability-weighted target $246 (-41% vs spot). P/E Multiple explains 89% of Monte Carlo outcome variance.

PANWEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -51.1%

Equity Research

Hewlett Packard Enterprise Co (HPE)

SELL. 12-month probability-weighted target $39 (-46% vs spot). P/E Multiple explains 55% of Monte Carlo outcome variance.

HPEEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -52.6%

Equity Research

Everpure, Inc. (P)

SELL. 12-month probability-weighted target $68 (-56% vs spot). P/E Multiple explains 73% of Monte Carlo outcome variance.

PEquity ResearchMonte Carlo

10 October 2026Rating: SELL · Fair value vs price -60.5%

Equity Research

Seagate Technology PLC (STX)

Rating suspended since 2026-09-29 — valuation method under review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

STXEquity ResearchMonte Carlo

10 October 2026Rating: N/A

Equity Research

Sitime Corporation (SITM)

SITMEquity ResearchMonte Carlo

10 October 2026Rating: N/A

Equity Research

Novanta Inc (NOVT)

Rating suspended since 2026-09-21 — valuation multiple under review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

NOVTEquity ResearchMonte Carlo

10 October 2026Rating: N/A

Equity Research

Micron Technology (MU)

Rating suspended since 2026-09-21 — valuation input under review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

MUEquity ResearchMonte Carlo

10 October 2026Rating: N/A

Equity Research

Fabrinet (FN)

FNEquity ResearchMonte Carlo

10 October 2026Rating: N/A

Equity Research

DigitalOcean Holdings Inc (DOCN)

DOCNEquity ResearchMonte Carlo

10 October 2026Rating: N/A

Equity Research

Broadcom Inc (AVGO)

Rating suspended since 2026-10-01 — under analyst review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

AVGOEquity ResearchMonte Carlo

10 October 2026Rating: N/A

Equity Research

Appfolio Inc (APPF)

APPFEquity ResearchMonte Carlo

10 October 2026Rating: N/A

Equity Research

Fair Isaac Corporation (FICO)

Rating suspended since 2026-09-30 — under analyst review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

FICOEquity ResearchMonte Carlo

29 September 2026Rating: N/A

Equity Research

TTM Technologies Inc (TTMI)

Rating suspended since 2026-09-20 — valuation input under review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

TTMIEquity ResearchMonte Carlo

19 September 2026Rating: N/A

Equity Research

Silicon Laboratories Inc (SLAB)

Rating suspended since 2026-10-10 — pending acquisition. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

SLABEquity ResearchMonte Carlo

30 July 2026Rating: N/A